Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study

• Hoofdauteurs: L. Bazzichi (Auteur), D. Biasi (Auteur), E. Tinazzi (Auteur), M. Muratore (Auteur), R. Pellerito (Auteur), R. Russo (Auteur), M. Corsaro Santi (Auteur), P. De Sandre (Auteur), O. Epis (Auteur), M. Granata (Auteur), B. Kroegler (Auteur), C. Meschini (Auteur), F. Versace (Auteur), C. Astolfi (Auteur)
• Formaat: Boek
• Gepubliceerd in: PAGEPress Publications, 2014-11-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The paper reports the results from the observational retrospective-prospective RUBINO study conducted in Italy to assess the safety of rituximab in the treatment of rheumatoid arthritis (RA) in routine clinical practice. The percentage of patients who manifested at least one grade 3 or 4 adverse eve...